In groups treated with stem cells expressing CD and/or IFN-β genes, expression of the PCNA protein decreased significantly in tumor burden of the brain, with a greater reduction occurring in the HB1.F3.CD.IFN-β cells treated group. This evidence concerns the gene IFNB1 and neoplasm.